Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Launched by M.D. ANDERSON CANCER CENTER · Oct 6, 2009

Keywords

ClinConnect Summary

This clinical trial is designed to gather important information about the side effects of proton therapy, a type of radiation treatment, in patients with various cancers including breast, lung, and head and neck cancers. By collecting data on how patients respond to this therapy both in the short term and long term, researchers hope to better understand the risks of side effects and the overall benefits of proton therapy for future patients.

If you are a patient scheduled to receive proton therapy at UTMD Anderson Cancer Center, you may be eligible to participate in this study. To join, you would need to sign a consent form agreeing to be part of the research. Participants can expect to share their experiences and will need to attend follow-up appointments either at the hospital or another location. It's important to note that if you cannot attend these follow-ups, you won't be able to participate in the trial. Overall, this study aims to improve treatment for future patients by learning more about proton therapy and its effects.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
• • Patients must sign a study-specific consent form prior to study entry
• Exclusion Criteria:
• • Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site